NEEDHAM, Mass., April 13, 2026 /PRNewswire/ -- Bracco, the market leader in diagnostic imaging and the pioneer in cardiac positron emission tomography (PET) for more than three decades, today affirmed ...
A new radioactive tracer for positron emission tomography (PET) myocardial perfusion imaging will soon be available in the United States, and it’s expected to facilitate substantial growth in such ...
The U.S. Food and Drug Administration (FDA) has approved flurpiridaz F-18 (Flyrcado; GE Healthcare), a first-of-its-kind positron emission tomography (PET) imaging agent, for use in adult patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results